IMB researchers are sharing their expertise in tackling drug-resistant bacteria with low and middle income countries, thanks to new funding from CARB-X.
Tackling antibiotic resistance and exploring the role of genomics in the novel coronavirus are the focus of new funding from the NHMRC, to fight infectious disease.
Ian Henderson, Professor of Microbiology, and Dr Larisa Labzin, Virologist, discuss COVID-19 – immunity, vaccine development, epidemiology and what we do and don’t know.